SVG Sprites


Press Release 03.01.2023

Lower Drug Prices Now on news that Eli Lilly will lower the cost of insulin

Let’s be clear, the tens of millions of Americans who can not afford their prescription medication should not have to depend on the good will of reedy corporations who have repeatedly shown they care about profits more than people to bring them relief from skyrocketing prescription costs.

Press Release 10.14.2022

LDPN: President Biden’s executive order will build upon the prescription drug benefits in the Inflation Reduction Act

The President’s executive order to rein in drug corporations’ monopoly control over prices comes in stark contrast to Senate Republicans’ introduction of legislation to repeal lower drug drug costs in the Inflation Reduction Act even before the law is implemented.

Press Release 08.12.2022

LDPN on House vote: “A huge defeat for Big Pharma”

Today is a huge defeat for Big Pharma and a huge victory for patients who have long endured the drug corporations’ relentless price-gouging. Pharma’s monopoly power to set and raise prices as high as they want has put affordable medicine out of the reach of millions of people for years and caused untold harm.

Press Release 08.07.2022

LDPN on Senate Passage Of The Inflation Reduction Act

We are now one, very important, step closer to a historic victory for consumers and a historic defeat for Big Pharma’s monopoly control over prescription drug prices.

LDPN In the News 07.11.2022

Quad-City Times: Grassley, Ernst explain opposition to Democratic prescription drug plan

DES MOINES — Iowa’s U.S. senators signaled opposition to a proposed plan from Senate Democrats aimed at lowering drug prices for Medicare recipients unveiled this week.

Sen. Joni Ernst and a spokesperson for Sen. Chuck Grassley, both Republicans, decried the plan as partisan in statements to the Lee Enterprises Des Moines Bureau.

LDPN In the News 07.01.2022

Lower Drug Prices Now on reports that Senate Democrats have reached a deal on prescription drug reform

This is a once in a generation chance for Democrats to finally deliver on their promises to lower drug prices. At a time when the price of everything is going up, this bill, if enacted, would finally rein in big Pharma’s price-gouging and make medicines more affordable for millions of Americans.

LDPN In the News 05.20.2022

Representative Susan Wild Leads Colleagues in Calling on Senate to Lower Prescription Drug Prices

Washington, DC – Yesterday, Representative Susan Wild, a champion for cutting costs for the people of Pennsylvania’s Seventh District, sent a letter signed by 19 colleagues, calling for Senate Majority Leader Chuck Schumer and Senate Committee on Finance Chairman Ron Wyden to provide relief for Americans by taking action to lower prescription drug prices through a reconciliation bill.

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles